Search research articles
Contact Us
Filters
Showing results (211-220 of 271) with videos related to
Page
of 28
Sort By:
Cancer Research
|
July 1, 1989
Chemoimmunotoxin therapy against a human colon tumor (HT-29) xenografted into nude mice
J W Pearson, D J FitzGerald, M C Willingham, et al.
British Journal of Obstetrics and Gynaecology
|
August 6, 1998
Reduced fetal exposure to aspirin using a novel controlled-release preparation in normotensive and hypertensive pregnancies
C L Regan, B F McAdam, P McParland, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
January 15, 2000
Prospective evaluation of the risk conferred by factor V Leiden and thermolabile methylenetetrahydrofolate reductase polymorphisms in pregnancy
R P Murphy, C Donoghue, R J Nallen, et al.
Reviews of Infectious Diseases
|
September 1, 1987
Use of Pseudomonas aeruginosa toxin A in the construction of conjugate vaccines and immunotoxins
S J Cryz, E Fürer, J C Sadoff, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
December 1, 1989
CD4-Pseudomonas exotoxin hybrid protein blocks the spread of human immunodeficiency virus infection in vitro and is active against cells expressing the envelope glycoproteins from diverse primate immunodeficiency retroviruses
E A Berger, K A Clouse, V K Chaudhary, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 1, 1990
Elimination of infectious human immunodeficiency virus from human T-cell cultures by synergistic action of CD4-Pseudomonas exotoxin and reverse transcriptase inhibitors
P Ashorn, B Moss, J N Weinstein, et al.
Annals of the New York Academy of Sciences
|
September 10, 1994
Selection of Pseudomonas exotoxin-resistant cells with altered expression of alpha 2MR/LRP
D J Fitzgerald, C M Fryling, A Zdanovsky, et al.
Nature
|
September 22, 1988
Selective killing of HIV-infected cells by recombinant human CD4-Pseudomonas exotoxin hybrid protein
V K Chaudhary, T Mizukami, T R Fuerst, et al.
The New England Journal of Medicine
|
July 28, 2001
Efficacy of the anti-CD22 recombinant immunotoxin BL22 in chemotherapy-resistant hairy-cell leukemia
R J Kreitman, W H Wilson, K Bergeron, et al.
Advances in Prostaglandin, Thromboxane, and Leukotriene Research
|
January 1, 1991
Mechanisms of eicosanoid action
G A FitzGerald, R Murray, N Moran, et al.
Page
of 28
Search research articles
Search
Showing results (211-220 of 271) with videos related to
Sort By:
Page
of 28
Cancer Research
|
July 1, 1989
Chemoimmunotoxin therapy against a human colon tumor (HT-29) xenografted into nude mice
J W Pearson, D J FitzGerald, M C Willingham, et al.
British Journal of Obstetrics and Gynaecology
|
August 6, 1998
Reduced fetal exposure to aspirin using a novel controlled-release preparation in normotensive and hypertensive pregnancies
C L Regan, B F McAdam, P McParland, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
January 15, 2000
Prospective evaluation of the risk conferred by factor V Leiden and thermolabile methylenetetrahydrofolate reductase polymorphisms in pregnancy
R P Murphy, C Donoghue, R J Nallen, et al.
Reviews of Infectious Diseases
|
September 1, 1987
Use of Pseudomonas aeruginosa toxin A in the construction of conjugate vaccines and immunotoxins
S J Cryz, E Fürer, J C Sadoff, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
December 1, 1989
CD4-Pseudomonas exotoxin hybrid protein blocks the spread of human immunodeficiency virus infection in vitro and is active against cells expressing the envelope glycoproteins from diverse primate immunodeficiency retroviruses
E A Berger, K A Clouse, V K Chaudhary, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 1, 1990
Elimination of infectious human immunodeficiency virus from human T-cell cultures by synergistic action of CD4-Pseudomonas exotoxin and reverse transcriptase inhibitors
P Ashorn, B Moss, J N Weinstein, et al.
Annals of the New York Academy of Sciences
|
September 10, 1994
Selection of Pseudomonas exotoxin-resistant cells with altered expression of alpha 2MR/LRP
D J Fitzgerald, C M Fryling, A Zdanovsky, et al.
Nature
|
September 22, 1988
Selective killing of HIV-infected cells by recombinant human CD4-Pseudomonas exotoxin hybrid protein
V K Chaudhary, T Mizukami, T R Fuerst, et al.
The New England Journal of Medicine
|
July 28, 2001
Efficacy of the anti-CD22 recombinant immunotoxin BL22 in chemotherapy-resistant hairy-cell leukemia
R J Kreitman, W H Wilson, K Bergeron, et al.
Advances in Prostaglandin, Thromboxane, and Leukotriene Research
|
January 1, 1991
Mechanisms of eicosanoid action
G A FitzGerald, R Murray, N Moran, et al.
Page
of 28